Phibro Animal Health (PAHC) Stock Price, News & Analysis

Company Overview

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products. The Animal Health segment offers an array of vaccines and pharmaceutical products targeting poultry, swine, cattle and aquaculture. Mineral Nutrition provides trace mineral supplements and premix solutions to optimize feed formulations, while Performance Products focuses on feed additives that improve nutrient utilization, gut health and production efficiency. Phibro’s products are used by producers, integrators and veterinary professionals to address disease prevention, growth promotion and regulatory compliance in modern animal agriculture.

With operations spanning North America, Latin America, Europe, the Middle East, Africa and Asia-Pacific, Phibro serves customers in more than 70 countries. The company traces its roots to the mid-20th century and has grown through strategic acquisitions, internal research and global partnerships to build a comprehensive suite of animal health solutions. Under the leadership of its President and Chief Executive Officer, Norbert G. Schaefer, Phibro continues to invest in innovation, regulatory approvals and manufacturing capabilities to meet evolving industry needs and support sustainable food production worldwide.

Key Stats

• Today's Range: $38.09 to $39.86
• 50-Day Range: $26.11 to $41.23
• 52-Week Range: $16.16 to $41.57
• Volume: 308,899 shs
• Average Volume: 312,601 shs
• Market Capitalization: $1.55 billion
• P/E Ratio: 32.47
• Dividend Yield: 1.25%
• Price Target: $28.40
• Consensus Rating: Hold

Phibro Animal Health Stock Analysis - MarketRank™

Phibro Animal Health scored higher than 92% of companies evaluated by MarketBeat, and ranked 85th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.9 / 5
• Analyst Rating: Hold

Consensus Rating

Phibro Animal Health has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 1 buy rating, 4 hold ratings, and 2 sell ratings.

Downside Risk

Phibro Animal Health has a consensus price target of $28.40, representing about 25.9% downside from its current price of $38.32.

Amount of Analyst Coverage

Phibro Animal Health has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 7.69%

Earnings Growth

Earnings for Phibro Animal Health are expected to grow by 7.69% in the coming year, from $1.95 to $2.10 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Phibro Animal Health is 32.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 263.99.

Price to Earnings Ratio vs. Sector

The P/E ratio of Phibro Animal Health is 32.47, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 78.05.

Price to Earnings Growth Ratio

Phibro Animal Health has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Phibro Animal Health has a P/B Ratio of 5.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.16% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 9.62%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Phibro Animal Health pays a meaningful dividend of 1.25%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Phibro Animal Health does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Phibro Animal Health is 40.68%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 22.86% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 1.1 / 5
• Environmental Score: -3.93

Percentage of Shares Shorted

4.16% of the float of Phibro Animal Health has been sold short.

Short Interest Ratio / Days to Cover

Phibro Animal Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Phibro Animal Health has recently decreased by 9.62%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 0.80

News Sentiment

Phibro Animal Health has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Phibro Animal Health this week, compared to 5 articles on an average week.

Search Interest

15 people have searched for PAHC on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.

MarketBeat Follows

8 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Phibro Animal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $995,893.00 in company stock.

Percentage Held by Insiders

50.13% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PAHC Stock Analysis - Frequently Asked Questions

How have PAHC shares performed this year?

Phibro Animal Health's stock was trading at $21.00 on January 1st, 2025. Since then, PAHC stock has increased by 82.5% and is now trading at $38.32.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corporation (NASDAQ:PAHC) announced its quarterly earnings data on Wednesday, August, 27th. The company reported $0.57 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.05. The company had revenue of $378.70 million for the quarter, compared to analysts' expectations of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a trailing twelve-month return on equity of 32.14%.
Read the conference call transcript.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Phibro Animal Health investors own include Solid Power (SLDP), Meta Platforms (META), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), AT&T (T) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 8/27/2025
• Record date for 9/24 Dividend: 9/03/2025
• Ex-Dividend for 9/24 Dividend: 9/03/2025
• Dividend Payable: 9/24/2025
• Today: 10/05/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:PAHC
• CIK: 1069899
• Web: www.pahc.com
• Phone: (201) 329-7300
• Fax: 201-329-7399
• Employees: 2,475
• Year Founded: 1946

Price Target and Rating

• Average Price Target for Phibro Animal Health: $28.40
• High Price Target: $35.00
• Low Price Target: $22.00
• Potential Upside/Downside: -25.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.13
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.18
• Trailing P/E Ratio: 32.47
• Forward P/E Ratio: 19.65
• P/E Growth: 1.16
• Net Income: $48.26 million
• Net Margins: 3.73%
• Pretax Margin: 5.25%
• Return on Equity: 32.14%
• Return on Assets: 6.89%

Debt

• Debt-to-Equity Ratio: 2.46
• Current Ratio: 2.76
• Quick Ratio: 1.25

Sales & Book Value

• Annual Sales: $1.30 billion
• Price / Sales: 1.20
• Cash Flow: $3.27 per share
• Price / Cash Flow: 11.72
• Book Value: $7.05 per share
• Price / Book: 5.44

Miscellaneous

• Outstanding Shares: 40,530,000
• Free Float: 20,214,000
• Market Cap: $1.55 billion
• Optionable: Optionable
• Beta: 0.83